Uncommon (formerly Higher Steaks) is a cultivated meat company focused on developing cultured pork products—notably bacon and pork belly—for the $250 billion global pork market. The company says it uses a patent-pending mRNA-based technique to instruct cells to make proteins, enabling real meat production without genetic engineering and reducing raw material needs. Uncommon argues this approach can lower costs and improve scalability compared with methods that rely on growth factors or gene editing. The business faces regulatory hurdles common to cultivated meat; Singapore is currently the only market selling such products and other jurisdictions remain pending. Uncommon plans to scale production and pursue regulatory approval in Europe and Singapore while keeping a close eye on the U.S., initially targeting high-end restaurants before moving to supermarkets. The company raised $30M in a Series A to support scaling and regulatory work.

Total raised

$30M

Funding rounds

1

Latest round

Series A

Latest activity

Jun 2023